Latest Prostate-specific antigen Stories
Phase III Trial Now Recruiting Patients SANTA ROSA, Calif., April 15, 2014 /PRNewswire/ -- A phase III clinical trial conducted at the Meir Medical Center in Kfar-Saba, Israel is now
-- Peak US urology organisation CUSP Group, LLC to evaluate MiStat(TM) technology SYDNEY, April 8, 2014 /PRNewswire/ -- Private Australian biotechnology company Minomic International
HOUSTON, April 7, 2014 /PRNewswire/ -- C4 Imaging LLC is pleased to announce the first patient implant with Sirius(TM), its novel positive-signal MRI Marker.
NORWALK, Conn., March 24, 2014 /PRNewswire/ -- UBM Medica US announces that Cancer Network, the online
Very small sample-size study incapable of showing cause-and-effect relationship WASHINGTON, March 3, 2014 /PRNewswire-USNewswire/ -- The American Chemistry Council (ACC) offers
New prostate cancer screening option combines existing tests to substantially increase accuracy CHICAGO, Feb.
Nomogram aims to enable informed decision-making and personalized treatment SEATTLE, Jan.
Using a nomogram that incorporates age, Gleason score, and prostate-specific antigen (PSA) level at diagnosis, individual risks that a screen-detected prostate cancer has been overdiagnosed can be estimated.
LOS ANGELES, Jan.
- The act of lurking; skulking about; hiding; keeping from sight.